Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 4, Pages 873-884
Publisher
Wiley
Online
2013-08-09
DOI
10.1002/ijc.28426
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma
- (2012) F. Cedeno-Laurent et al. BLOOD
- Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
- (2012) Hilko Ardon et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Galectin-1 Deactivates Classically Activated Microglia and Protects from Inflammation-Induced Neurodegeneration
- (2012) Sarah C. Starossom et al. IMMUNITY
- Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
- (2011) P. Allavena et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Galectin-1 and immunotherapy for brain cancer
- (2011) Tina Verschuere et al. Expert Review of Neurotherapeutics
- Metabolic Inhibition of Galectin-1-Binding Carbohydrates Accentuates Antitumor Immunity
- (2011) Filiberto Cedeno-Laurent et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model
- (2010) Kimberley A. Stannard et al. CANCER LETTERS
- Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy
- (2010) Xinmei Zhu et al. JOURNAL OF NEURO-ONCOLOGY
- Tolerogenic Dendritic Cells in the Control of Autoimmune Neuroinflammation: An Emerging Role of Protein-Glycan Interactions
- (2010) Juan M. Ilarregui et al. NEUROIMMUNOMODULATION
- Galectins and Gliomas
- (2009) Marie Le Mercier et al. BRAIN PATHOLOGY
- Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses
- (2009) Marie Le Mercier et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma
- (2009) Wim Maes et al. NEURO-ONCOLOGY
- Glioblastoma-Derived Mechanisms of Systemic Immunosuppression
- (2009) Allen Waziri NEUROSURGERY CLINICS OF NORTH AMERICA
- Postoperative Adjuvant Dendritic Cell-Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme
- (2008) S. De Vleeschouwer et al. CLINICAL CANCER RESEARCH
- Galectin-1 Is a Novel Structural Component and a Major Regulator of H-Ras Nanoclusters
- (2008) Liron Belanis et al. MOLECULAR BIOLOGY OF THE CELL
- Macrophage polarization in tumour progression
- (2008) Antonio Sica et al. SEMINARS IN CANCER BIOLOGY
- Evidence of galectin-1 involvement in glioma chemoresistance☆
- (2008) Marie Le Mercier et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started